Stock Information
Nektar Therapeutics (NKTR)
Ticker Symbol: NKTR
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,311.90 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -9.8084
Revenue (TTM): $2.72 M
Dividend Yield: N/A%
ROE: -184.69%
Latest News
-
Stay Invested In U.S. Stocks, Don't Panic Sell, Also Buy Gold
Sun, Mar 22, 2026 9:44 PM
-
Nektar Therapeutics Announces New Data From Phase 2b Studies In Dermatitis And Alopecia Treatment Rezpegaldesleukin Has Been Accepted For Two Oral Presentations At The 2026 AAD Annual Meeting, March 27-31
Fri, Mar 20, 2026 10:02 AM
-
TD Cowen Initiates Coverage On Nektar Therapeutics with Buy Rating
Tue, Mar 17, 2026 10:45 AM
Key Financials
Financial data not available
